COMPLAINTS—DRUGS—N.J.SUPER.: SINGULAIR® ALLEGEDLY INCREASES RISK OF PEDIATRIC NEUROPSYCHIATRIC SIDE EFFECTS
(C.C.H.)
•
By Pamela C. Maloney, J.D.
•
Copyright (c) CCH INCORPORATED, A Wolters Kluwer business. All rights reserved.
•
Products Liability Law Daily Wrap Up
•
News: Story
Wolters Kluwer Products Liability Law Daily
•
May 10, 2021
A patient has sued the maker of a prescription asthma drug for defective design and failure to warn of the drug's neuropsychiatric side effects, especially in pediatric patients.
A pediatric patient, who developed neuropsychiatric injuries allegedly...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.